Titre : Contamination radioactive des aliments

Contamination radioactive des aliments : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cell Line Authentication
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Contamination radioactive des aliments : Questions médicales les plus fréquentes", "headline": "Contamination radioactive des aliments : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Contamination radioactive des aliments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-03", "dateModified": "2025-03-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Contamination radioactive des aliments" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hygiène radiologique", "url": "https://questionsmedicales.fr/mesh/D011870", "about": { "@type": "MedicalCondition", "name": "Hygiène radiologique", "code": { "@type": "MedicalCode", "code": "D011870", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.810" } } }, "about": { "@type": "MedicalCondition", "name": "Contamination radioactive des aliments", "alternateName": "Food Contamination, Radioactive", "code": { "@type": "MedicalCode", "code": "D005507", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "I Ye Kolpakov", "url": "https://questionsmedicales.fr/author/I%20Ye%20Kolpakov", "affiliation": { "@type": "Organization", "name": "State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine." } }, { "@type": "Person", "name": "V Yu Vdovenko", "url": "https://questionsmedicales.fr/author/V%20Yu%20Vdovenko", "affiliation": { "@type": "Organization", "name": "State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine." } }, { "@type": "Person", "name": "Ryszard Misiak", "url": "https://questionsmedicales.fr/author/Ryszard%20Misiak", "affiliation": { "@type": "Organization", "name": "Institute of Nuclear Physics, Polish Academy of Sciences, Radzikowskiego 152, 31-342 Kraków, Poland." } }, { "@type": "Person", "name": "Yuki Sato", "url": "https://questionsmedicales.fr/author/Yuki%20Sato", "affiliation": { "@type": "Organization", "name": "Collaborative Laboratories for Advanced Decommissioning Science, Japan Atomic Energy Agency, 790-1 Motooka aza Ohtsuka, Tomioka-machi, Futaba-gun, Fukushima, Japan. Electronic address: sato.yuki@jaea.go.jp." } }, { "@type": "Person", "name": "Vladimir Drozdovitch", "url": "https://questionsmedicales.fr/author/Vladimir%20Drozdovitch", "affiliation": { "@type": "Organization", "name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 9609 Medical Center Drive, Room 7E548 MSC 9778, Bethesda, MD, 20892-9778, USA. drozdovv@mail.nih.gov." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "First line antiretroviral treatment failure and its association with drug substitution and sex among children in Ethiopia: systematic review and meta-analysis.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36316358", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-22237-6" } }, { "@type": "ScholarlyArticle", "name": "Routine first-line detection of breast cancer therapy-related cardiotoxicity by serial, fast and ultra-low-dose equilibrium radionuclide angiography.", "datePublished": "2022-10-26", "url": "https://questionsmedicales.fr/article/36289164", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12350-022-03124-z" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244915", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.urolonc.2022.09.011" } }, { "@type": "ScholarlyArticle", "name": "An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.", "datePublished": "2022-10-10", "url": "https://questionsmedicales.fr/article/36231138", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells11193176" } }, { "@type": "ScholarlyArticle", "name": "Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced", "datePublished": "2022-10-06", "url": "https://questionsmedicales.fr/article/36230817", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cancers14194894" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Hygiène radiologique", "item": "https://questionsmedicales.fr/mesh/D011870" }, { "@type": "ListItem", "position": 5, "name": "Contamination radioactive des aliments", "item": "https://questionsmedicales.fr/mesh/D005507" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Contamination radioactive des aliments - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Contamination radioactive des aliments", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Contamination radioactive des aliments", "description": "Comment détecte-t-on la contamination radioactive des aliments ?\nQuels sont les indicateurs de contamination radioactive ?\nLes inspections alimentaires incluent-elles la radioactivité ?\nQuels appareils mesurent la radioactivité dans les aliments ?\nPeut-on détecter la radioactivité par des méthodes visuelles ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Contamination radioactive des aliments", "description": "Quels symptômes indiquent une exposition à des aliments radioactifs ?\nLa contamination radioactive cause-t-elle des maladies ?\nLes symptômes apparaissent-ils immédiatement après ingestion ?\nY a-t-il des symptômes spécifiques pour les enfants ?\nComment la radioactivité affecte-t-elle le système immunitaire ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Contamination radioactive des aliments", "description": "Comment prévenir la contamination radioactive des aliments ?\nLes contrôles de sécurité alimentaire sont-ils efficaces ?\nQuelles sont les recommandations pour les agriculteurs ?\nLes consommateurs peuvent-ils réduire les risques ?\nLes étiquettes alimentaires indiquent-elles la radioactivité ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Contamination radioactive des aliments", "description": "Quel traitement existe pour la contamination radioactive ?\nLes soins d'urgence sont-ils nécessaires en cas d'exposition ?\nPeut-on utiliser des médicaments pour réduire les effets ?\nLa décontamination des aliments est-elle possible ?\nQuels sont les soins post-exposition recommandés ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Contamination radioactive des aliments", "description": "Quelles complications peuvent survenir après exposition ?\nLa contamination radioactive affecte-t-elle la reproduction ?\nLes effets de la radioactivité sont-ils réversibles ?\nY a-t-il des risques pour les générations futures ?\nComment la radioactivité affecte-t-elle la santé mentale ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Contamination radioactive des aliments", "description": "Quels sont les principaux facteurs de risque de contamination ?\nLes aliments importés présentent-ils un risque ?\nLes conditions climatiques influencent-elles la contamination ?\nLes populations vulnérables sont-elles plus à risque ?\nL'alimentation biologique est-elle plus sûre ?", "url": "https://questionsmedicales.fr/mesh/D005507?mesh_terms=Cell+Line+Authentication&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on la contamination radioactive des aliments ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de radiométrie et des analyses de laboratoire sont utilisés pour détecter la radioactivité." } }, { "@type": "Question", "name": "Quels sont les indicateurs de contamination radioactive ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de radiation mesurés en becquerels par kilogramme d'aliment sont des indicateurs clés." } }, { "@type": "Question", "name": "Les inspections alimentaires incluent-elles la radioactivité ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les inspections peuvent inclure des tests pour la radioactivité dans les aliments." } }, { "@type": "Question", "name": "Quels appareils mesurent la radioactivité dans les aliments ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des détecteurs de radiation et des spectromètres gamma sont couramment utilisés." } }, { "@type": "Question", "name": "Peut-on détecter la radioactivité par des méthodes visuelles ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, la radioactivité ne peut pas être détectée visuellement; des instruments spécifiques sont nécessaires." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition à des aliments radioactifs ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure nausées, vomissements, fatigue et troubles gastro-intestinaux." } }, { "@type": "Question", "name": "La contamination radioactive cause-t-elle des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des maladies graves, y compris des cancers." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils immédiatement après ingestion ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours; certains effets peuvent prendre des jours ou des mois à se manifester." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques pour les enfants ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent être plus sensibles et présenter des symptômes plus graves que les adultes." } }, { "@type": "Question", "name": "Comment la radioactivité affecte-t-elle le système immunitaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut affaiblir le système immunitaire, rendant l'individu plus vulnérable aux infections." } }, { "@type": "Question", "name": "Comment prévenir la contamination radioactive des aliments ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les zones contaminées et suivre les recommandations des autorités sanitaires." } }, { "@type": "Question", "name": "Les contrôles de sécurité alimentaire sont-ils efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers aident à détecter et prévenir la contamination radioactive." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les agriculteurs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'utilisation d'eau contaminée et surveiller les niveaux de radiation dans le sol." } }, { "@type": "Question", "name": "Les consommateurs peuvent-ils réduire les risques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en choisissant des aliments provenant de sources sûres et en suivant les alertes sanitaires." } }, { "@type": "Question", "name": "Les étiquettes alimentaires indiquent-elles la radioactivité ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Non, la radioactivité n'est généralement pas indiquée sur les étiquettes alimentaires." } }, { "@type": "Question", "name": "Quel traitement existe pour la contamination radioactive ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des agents chélateurs pour éliminer les radionucléides du corps." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires en cas d'exposition ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins d'urgence peuvent être nécessaires pour traiter les symptômes aigus." } }, { "@type": "Question", "name": "Peut-on utiliser des médicaments pour réduire les effets ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent aider à atténuer certains effets, mais ne neutralisent pas la radioactivité." } }, { "@type": "Question", "name": "La décontamination des aliments est-elle possible ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Non, une fois contaminés, les aliments radioactifs ne peuvent pas être décontaminés efficacement." } }, { "@type": "Question", "name": "Quels sont les soins post-exposition recommandés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Surveillance médicale et tests réguliers pour détecter d'éventuels effets à long terme." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des cancers, des maladies thyroïdiennes et des troubles immunitaires." } }, { "@type": "Question", "name": "La contamination radioactive affecte-t-elle la reproduction ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des problèmes de fertilité et des malformations congénitales." } }, { "@type": "Question", "name": "Les effets de la radioactivité sont-ils réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certains effets peuvent être réversibles, mais d'autres, comme le cancer, peuvent ne pas l'être." } }, { "@type": "Question", "name": "Y a-t-il des risques pour les générations futures ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la contamination peut avoir des effets héréditaires sur les générations futures." } }, { "@type": "Question", "name": "Comment la radioactivité affecte-t-elle la santé mentale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut causer de l'anxiété, du stress et des troubles psychologiques chez les exposés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de contamination ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les zones proches de centrales nucléaires et les sites d'accidents nucléaires sont à risque." } }, { "@type": "Question", "name": "Les aliments importés présentent-ils un risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains aliments importés peuvent être contaminés, surtout en provenance de zones à risque." } }, { "@type": "Question", "name": "Les conditions climatiques influencent-elles la contamination ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des événements comme les pluies acides peuvent augmenter la contamination des sols et des cultures." } }, { "@type": "Question", "name": "Les populations vulnérables sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants, les femmes enceintes et les personnes immunodéprimées sont plus vulnérables." } }, { "@type": "Question", "name": "L'alimentation biologique est-elle plus sûre ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Pas nécessairement; la contamination peut affecter tous les types d'aliments, y compris biologiques." } } ] } ] }

Sources (10000 au total)

Routine first-line detection of breast cancer therapy-related cardiotoxicity by serial, fast and ultra-low-dose equilibrium radionuclide angiography.

This study assesses a first-line left ventricular ejection fraction (LVEF) monitoring provided by an ultra-low-dose equilibrium radionuclide angiography (ERNA) in breast cancer women treated with pote... Breast cancer women treated with anthracyclines, followed or not by trastuzumab, were monitored using ERNA with a high-sensitivity CZT-camera. Calibrated LVEF measurements were obtained with an almost... During a mean 24 ± 6 months follow-up, 552 ERNAs with a mean effective dose of 2.3 ± 0.6 mSv were performed in 195 women, among whom 22 (11%) presented both ERNA criteria of cardiotoxicity (LVEF < 50%... First-line detection of breast cancer therapy-related cardiotoxicity by ultra-low-dose ERNA provides consistent results, confirming the excellent cardiac outcome for the greatest majority of women wit...

Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany.

Since multiple oncological treatment options in metastatic castration-resistant prostate cancer (mCRPC) are available, optimal sequencing of therapies are under investigation. However, the efficacy of... Fifty three patients with mCRPC treated with CAB in fourth line or later were included in our retrospective study, which involved eight uro-oncology centers in Germany. Clinical and tumor characterist... Of 53 patients, 79% (n=42), 19% (n=10) and 2% (n=1) received CAB in fourth, fifth and sixth line. A median of 4 cycles of CAB were administered. Median PSA at start of CAB was 199ng/ml (interquartile ... Real-world experiences indicate that favorable oncologic outcomes can be achieved with CAB especially regarding PSA-response and OS even in the fourth line or later in patients with mCRPC....

An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.

Epidermal growth factor receptor (EGFR) pathway has been shown to play a crucial role in several inflammatory conditions and host immune-inflammation status is related to tumor prognosis. This study a...

Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice.

Regorafenib is the first oral targeted drug as a second-line agent in patients with advanced hepatocellular carcinoma (HCC) who progressed on sorafenib treatment. Recently, several studies demonstrate... From October 2018 to January 2022, our retrospective study evaluated advanced HCC patients who received regorafenib with PD-1 inhibitors or regorafenib alone as a second-line treatment at the Second A... In total, 78 patients were enrolled in our study and were separated into two groups - RP group (48) and R group (30) - according to the criteria. The ORR of RP group and R group was 18.8% and 10%, res... In the second-line therapy of advanced HCC, compared to regorafenib alone, the combination of regorafenib and PD-1 inhibitors showed promising efficacy and tolerable drug toxicity....

Outcomes of Second-Line Intravitreal Anti-VEGF Switch Therapy in Radiation Retinopathy Secondary to Uveal Melanoma: Moving from Bevacizumab to Aflibercept.

Radiation retinopathy is a dose-dependent complication of the retina following exposure to ionizing radiation. The objective of this prospective case series is to determine the clinical efficacy of in... A case series of 30 patients with a mean age of 57 ± 15 years with radiation retinopathy were enrolled. Visual acuity (VA) and central foveal thickness (CFT) responses to therapy were assessed with re... Regression analyses showed a statistically significant reduction in CFT and improvements in VA following the switch to treatment by aflibercept at 1 month, 3 months, and 6 months. The mean CFT improve... This pilot study suggests that patients with radiation retinopathy who have failed monthly intravitreal bevacizumab may respond to aflibercept....

A mental health survey among young front-line clinicians in high-risk areas during the COVID-19 sporadic epidemic in China.

The sporadic coronavirus disease (COVID-19) epidemic has placed enormous psychological stress on people, especially clinicians. The objective of this study was to examine depression, anxiety, quality ... In this cross-sectional study, demographic information, COVID-19-related questions, anxiety (Generalized Anxiety Disorder-7, GAD-7), depression (Patient Health Questionnaire-9, PHQ-9), insomnia (Insom... A total of 146 young front-line clinicians were included. The prevalence rates of depression, anxiety, and anxiety-depression comorbidity were 37.7% (95% CI = 29.7-45.6%), 26.0% (95% CI = 18.8-33.2%),... The prevalence of depression, anxiety, and even anxiety-depression comorbidity was high among young front-line clinicians in high-risk areas during the COVID-19 sporadic epidemic in China. Various bio...